chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: Muscle pain and sore muscle; This is a spontaneous report received from a contactable consumer, the patient. A 46-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot no: UNKNOWN) (at the age of 46-Years-Old) via an unspecified route on right arm on 03Mar2021, at 13:00 hours as a single dose for COVID-19 immunisation. Medical history included allergy related asthma (allergic asthma). Concomitant medications were not reported and no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested positive for COVID-19. It was reported that the patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 03Mar2021, at 13:00 hours, the patient experienced muscle pain in the shoulder area of arm where shot was given. As reported, first few days sharp stabbing pain, then sore muscle (myalgia) and shot site was normal after a few hours next day. The patient did not receive any treatment for events. The clinical outcome of myalgia was recovered at an unspecified date in Mar2021, at the time of report. No follow-up attempts are possible. Information about lot/batch number cannot be obtained.
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Asthenia, Body temperature, Chills, Fatigue
Clinical narrative: just tired; nausea; gas along with weakness; Gas along with weakness; chills; joint pain in knees; Arm Soreness; Midnight Fever developed; This is a spontaneous report from a non-contactable consumer, the patient. A 39-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER2613) via an unspecified route of administration in the left arm on 17Mar2021 at 15:30 (at the age of 39-years-old), as a single dose for COVID-19 immunisation. Medical history included hypertension and COVID-19. Concomitant medications included Lisinopril/HCTZ (MANUFACTURER UNKNOWN) 20-25 mg from an unknown date for unknown indication. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6202) via an unspecified route of administration in the left arm on 24Feb2021 at 15:30 (at the age of 39-years-old), as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was diagnosed with COVID-19 on an unknown date. Since the vaccination, the patient had not been tested for COVID-19. The patient had not received any other vaccines within four weeks prior to the COVID-19 vaccine. On 17Mar2021, the patient experienced arm soreness that started and worsened at 20:00, joint pain in knees at 20:45, chills at 22:00 and at midnight fever developed. On 18Mar2021, the patient experienced nausea and gas along with weakness at 02:00, 103 (unspecified units) fever at 04:00, which was still bad at 06:00; fever falling strength recovery at 08:00, just tired and arm sore at 10:00, was same at noon and 14:00 and at 16:00, just the arm for another 24 hours. The patient did not receive any treatment for the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events joint pain in knees, chills, fever, nausea, gas, weakness, fever, pain in arm and tiredness was recovered on an unknown date.   No follow-up attempts are possible. No further information is expected.
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Flatulence, Nausea, Pain in extremity, Pyrexia
Clinical narrative: just tired; nausea; gas along with weakness; Gas along with weakness; chills; joint pain in knees; Arm Soreness; Midnight Fever developed; This is a spontaneous report from a non-contactable consumer, the patient. A 39-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER2613) via an unspecified route of administration in the left arm on 17Mar2021 at 15:30 (at the age of 39-years-old), as a single dose for COVID-19 immunisation. Medical history included hypertension and COVID-19. Concomitant medications included Lisinopril/HCTZ (MANUFACTURER UNKNOWN) 20-25 mg from an unknown date for unknown indication. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6202) via an unspecified route of administration in the left arm on 24Feb2021 at 15:30 (at the age of 39-years-old), as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was diagnosed with COVID-19 on an unknown date. Since the vaccination, the patient had not been tested for COVID-19. The patient had not received any other vaccines within four weeks prior to the COVID-19 vaccine. On 17Mar2021, the patient experienced arm soreness that started and worsened at 20:00, joint pain in knees at 20:45, chills at 22:00 and at midnight fever developed. On 18Mar2021, the patient experienced nausea and gas along with weakness at 02:00, 103 (unspecified units) fever at 04:00, which was still bad at 06:00; fever falling strength recovery at 08:00, just tired and arm sore at 10:00, was same at noon and 14:00 and at 16:00, just the arm for another 24 hours. The patient did not receive any treatment for the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events joint pain in knees, chills, fever, nausea, gas, weakness, fever, pain in arm and tiredness was recovered on an unknown date.   No follow-up attempts are possible. No further information is expected.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Cough, Fatigue, Head discomfort, Pyrexia
Clinical narrative: head congestion; cough at night; chills; extreme fatigue; fever at night; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old non-pregnant female patient received her first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6205) via an unspecified route of administration in the right arm on 10Mar2021 (at the age of 53-years-old) as a single dose for COVID-19 immunisation. Medical history included attention deficit hyperactivity disorder (ADHD). The patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, the patient had not been tested positive for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medication that was taken within 2 weeks of vaccination included amphetamine (ADDERRALL) and Multiple vitamins for unknown indication. On 13Mar2021, the patient had experienced extreme fatigue, head congestion, chills, cough at night and fever at night. The patient received over the counter remedies as a part of treatment for the reported events. Adverse events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events extreme fatigue, head congestion, chills, cough at night and fever at night was resolving at the time of report. No follow-up attempts are possible. No further information is expected.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Nausea, Pyrexia, Vomiting
Clinical narrative: Severe nausea; Vomiting; Low fever; Chills; This is a spontaneous report received from a contactable consumer, the patient. A 27-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA vaccine; Lot number: ep 6955), via an unspecified route of administration on left arm on 19Mar2021 at 12:45 (at the age of 27 years), as a single dose for COVID-19 immunisation. Medical history was not reported. The patient did not have any allergic conditions. Concomitant medications included SEASONIQUE, gabapentin (MANUFACTURER UNKNOWN) and melatonin (MANUFACTURER UNKNOWN) started on an unknown date used for an unknown indication. Prior to vaccination, the patient had no symptoms associated for COVID-19. Since the vaccination, the patient was not tested positive for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the suspect vaccine. On 19Mar2021 at 21:00, the patient experienced severe nausea and started vomiting. The patient had a low fever and chills and couldn't stop vomiting. The patient couldn't keep water down for about 4 hours. The clinical outcome of events severe nausea, vomiting, low fever and chills were resolved on an unknown date in Mar2021.    No follow-up attempts are needed. No further information is expected.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Injection site pain, Pain
Clinical narrative: This is a spontaneous report received from a contactable consumer, the patient. A 64-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER2613) via an unspecified route of administration in the left arm on 20Mar2021 at 15:00 (at the age of 64-years-old), as single dose for COVID-19 immunisation. The patient medical history included depression, GERD, PTSD, mild seasonal and dust allergies, rosacea, mild asthma, cancer survivor (15 years), and allergy to sulfa drugs. Concomitant medications were not reported. Prior to vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Since the vaccination, the patient had not been tested for COVID-19. On 20Mar2021 at 20:00, the patient experienced mild soreness in his left arm at injection point, fatigue, body aches. Arm pain noticed about 5 hours after inoculation. He awoke the next morning with aches and fatigue, about 18 hours after injection. Therapeutic measure were not taken as a result of the events. The clinical outcome of soreness in left arm at injection point, fatigue, body aches was resolving.   No follow-up attempts are needed. No further information is expected.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Vaccination site pain
Clinical narrative: Muscle soreness; Muscle soreness at site of injection; This is a spontaneous report received from a non-contactable consumer, the patient. A 50-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: PAA165969), via an unspecified route administration in the left arm on 18Mar2021 at 15:00 (at the age of 50-years-old), as a single dose for COVID-19 immunisation. Medical history included Hashimoto's. Concomitant medication included levothyroxine (MANUFACTURER UNKNOWN), progesterone (MANUFACTURER UNKNOWN), ZYRTEC, doxylamine (MANUFACTURER UNKNOWN); all for unknown indication from an unknown date. The patient previously received BACTRIM and experienced allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 18Mar2021 at 21:00, the patient experienced muscle soreness at site of injection for 24-48 hours. The patient did not receive any treatment for events. The events didn't result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of events muscle soreness and muscle soreness at site of injection were resolving at the time of this report.   No follow-up attempts are possible. No further information is expected.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: Ringing in ears; This is a spontaneous report received from a contactable consumer, the patient. A 55-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: En6205), via an unspecified route of administration in the left arm on 05Mar2021 at 12:00 (at the age of 55-years-old) as a single dose, for COVID-19 immunisation. Medical history included sulfa allergy. Concomitant medication included propanol (MANUFACTURER UNKNOWN) for unknown indication. The patient previously received her first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: El9267), via an unspecified route of administration in the left arm on 12Feb2021 at 12:00 (at the age of 55-years-old) for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. On 20Mar2021 at 07:00, the patient experienced ringing in ears. The adverse events resulted in doctor or other healthcare professional office/clinic visit. It was unknown if any therapeutic measure were taken for the event. The clinical outcome of ringing in ears was not resolved.  No follow-up attempts are needed. No further information is expected.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Depressed mood, Fatigue, Nausea, Oropharyngeal pain
Clinical narrative: feeling rundown; Sore throat; General fatigue; Queasiness; This is a spontaneous report from a non-contactable consumer, the patient. A 29-year-old non pregnant female patient received first dose of BNT162B2 (Pfizer BioNTech Covid19 mRNA lot number ER8727) via unspecified route of administration in the left arm on 18Mar2021 as a single dose for COVID-19 immunisation. Concomitant medication details were not reported. It was reported that the patient was allergic to minocycline (MANUFACTURER UNKNOWN). It was reported that the patient did not take any other vaccines in four weeks. The patient was not diagnosed with COVID-19, prior vaccination. The patient has not tested for COVID-19 post vaccination. On 19Mar2021, the patient had sore throat, feeling run-down, queasiness, general fatigue. It was reported that the patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events was resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Vaccination site pain
Clinical narrative: Entire left arm is aching; Injection site is still very tender and sore; This is a spontaneous report received from a contactable consumer, the patient. A 36-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration in the left arm on 19Mar2021 at 07:15 (at the age of 36-years-old), as a single dose for COVID-19 immunisation. The patient had no medical history reported. The patient did not have allergies to medications, food, or other products. Concomitant medication included unspecified prenatal medications, but took only occasionally for an unspecified indication from unknown date. The patient previously received flu vaccine (MANUFACTURER UNKNOWN), for an unspecified indication. The patient always had her flu shot and it never hurts. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. On 19Mar2021, at 22:00, the patient's entire left arm was aching and did not experience regular pain. The pain was throughout her entire left arm and the injection site was very tender and sore till the time of this report. The adverse event did not result in a visit to the doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive treatment for the reported events vaccination site pain and left arm pain. The clinical outcomes of the events vaccination site pain and left arm pain were not recovered.  Information about lot/batch number cannot be obtained. No further information is expected.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Lymph node pain, Lymphadenopathy
Clinical narrative: pain of the jugulo-digastric (tonsilar), subparotid andpreauricular lymph nodes; Swelling and pain of the jugulo-digastric (tonsilar), subparotid, and preauricular lymph nodes; This is a spontaneous report received from a contactable consumer, the patient. A 28-years-old non-pregnant female patient received her second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN via an unspecified route of administration in left arm on 19Mar2021 at 16:00 (at the age of 28-years-old) as a single dose, for COVID-19 immunisation. Medical history, concomitant medications of the patient were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN via an unspecified route of administration in left arm on 19Feb2021 at 12:00 (at the age of 28-years-old) as a single dose, for COVID-19 immunisation. The patient had not received any other vaccine within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient not had any allergies to medications, food, or other products. The patient experienced lymph node pain and swollen lymph nodes on 20Mar2021 at 15:45 (Swelling and pain of the jugulo-digastric (tonsillar), sub parotid, and preauricular lymph nodes that began one day after vaccination). The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient had not received any treatment for events swollen lymph nodes and lymph node pain. The clinical outcome of lymph node pain and swollen lymph nodes was not resolved.   Information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021324484 similar report from same reporter
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Blood pressure measurement, Hypotension
Clinical narrative: Blood pressure dipped to 85/56; This is a spontaneous report from a non-contactable consumer, the patient. A 60-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: en6206) via an unspecified route of administration in left arm on 17Mar2021 at 13:15 (at the age of 60-year-old) as a single dose, for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient had no known allergies to medications, food or other products. The patient did not receive any other vaccines within 4 weeks prior to COVID-19 vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested positive for COVID-19. On 17Mar2021 at 19:30 (approximately 6 hours later), the patient blood pressure dipped to 85/5. No therapeutic measures were taken as a result of the event. The adverse events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. The clinical outcome of event hypotension was resolved on an unknown date.   No follow-up attempts are needed. No further information is expected.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: Dizziness especially in the morning; This is a spontaneous report received from a contactable consumer, the patient. A 63-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot no: EN6198) via an unspecified route of administration in the left arm on 05Mar2021 at 10:30 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. Medical history included prothrombin gene mutation; being treated with warfarin 5 milligram. The patient did not have any allergies to medications, food, or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included warfarin (MANUFACTURER UNKNOWN) 5mg for prothrombin gene mutation. The patient did not receive any other vaccines within four weeks prior to the vaccination. Since the vaccination, the patient had not been tested for COVID-19. On 20Mar2021 at 08:00, the patient experienced dizziness especially in the morning. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the adverse events. The clinical outcome of dizziness especially in the morning was not recovered. No follow-up attempts are needed. No further information is expected.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Headache, Nausea
Clinical narrative: diarrhea; nausea; light headache; This is a spontaneous report received from a contactable other health care professional, the patient. A 63-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP6955) as a single dose via an unspecified route of administration in her left arm on 19Mar2021 at 11:30 (at the age of 63-years-old) for COVID-19 immunisation. Medical history (reported as yes) without any specified condition. The patient had unspecified allergies to medications, food or other products. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. The patient received unspecified medications within 2 weeks of vaccination. The patient had not been tested COVID-19, prior to vaccination. The patient had not been tested for COVID-19, since having the vaccination. On day of injections on 19Mar2021, the patient reported as she had experienced light headache and next day on 20Mar2021 at 06:00, the patient woke-up with diarrhea and nausea, as the day progressed it got worsened and then got better today, but patient woke up again on 21Mar2021, with extreme diarrhoea and nausea, every time I try to eat, I have to go to the bathroom. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. It was reported that patient did not received treatments for the events headache, diarrhea and nausea. The clinical outcome for the events diarrhea, headache and nausea were not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Hypoaesthesia, Hypoaesthesia oral, Taste disorder
Clinical narrative: Entire left side of face and inside left mouse has a tingling sensation; Weird taste in mouth; Headache; inside left mouse has a tingling sensation; This is a spontaneous report received from a contactable consumer, the patient. A 66-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP7534) via unspecified route of administration on left arm on 12Mar2021 at 13:15 (at the age of 66-year-old) as a single dose for COVID-19 immunisation. The past medical history included thyroid and tetanus. The concomitant medication included SYNTHROID since an unspecified date and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 17Mar2021, the patient experienced a tingling sensation on entire left side of face and inside left mouse(mouth), weird taste in mouth and headache. The events did not result in a doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care visit. No therapeutic measures taken in response to the event. The clinical outcome of the events tingling sensation, taste disorder and headache was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Vaccination site pain
Clinical narrative: Severe arm pain; Moderate to severe arm pain extending from the injection site; This is a spontaneous report received from a contactable other health care professional. A 62-years-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EN6198) via intramuscular route in the left arm on 09Mar2021 (age at vaccination 62-years-old) as single dose for COVID-19 immunisation. Medical history included kidney transplant 20 years back and patient was on immunosuppressive agents. The concomitant medication included Immunosuppressive agents given after transplant. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. On 09Mar2021following the first vaccination experienced moderate to severe arm pain extending from the injection site in her shoulder down the entire length of her arm. The pain has persisted but is now resolving ten days post. The patient did not received treatment for the reported events. The clinical outcome of events vaccination site pain and severe arm pain was recovering at the time of this reporting.   No follow-up attempts are needed. No further information is expected.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Rash erythematous
Clinical narrative: This is a spontaneous report received from a contactable consumer, the patient. A 70-years-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6199) via an unspecified route of administration in the right arm on 19Mar2021 at 10:30 (at the age of 70-years-old), as a single dose for COVID-19 immunisation. The patients medical history included rash from flu vaccine several years ago and hay fever. The patient was allergic to various medications (unspecified). Concomitant medications included vitamin B (MANUFACTURER UNKNOWN), vitamin D (MANUFACTURER UNKNOWN) and vitamin C (MANUFACTURER UNKNOWN) for unspecified indication. The patient received these medications within 2 weeks of vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6200) via an unspecified route of administration at right arm on 26Feb2021 at 11:00 as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine.  Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 21Mar2021, 43 hours after receiving the second dose of vaccine, the patient experienced raised red rash which was spreading on trunk, legs, arms and neck. Therapeutic measure taken as a result of the event red rash included ALLEGRA. The clinical outcome of event red rash spreading on trunk, legs and arms and neck was not resolved at the time of reporting. No follow-up attempts are needed. No further information is expected.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Nausea, Pyrexia
Clinical narrative: Vomiting; Nausea; Pain at injection site; Fever; Chills; Headache; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 25-year-old non pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6208; Dose: UNKNOWN) via an unspecified route of administration in the left arm on 19Mar2021 at 16:00, (at the age of 25 years old) as a single dose for COVID-19 immunisation. Medical history included asthma and irritable bowel syndrome. The patient was allergic to dairy products. Concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 19Mar2021, the patient experienced pain at injection site, fever, chills, headache, and fatigue. On 22Mar2021, the patient experienced vomiting, and nausea. No therapeutic measures were taken as result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of events pain at injection site, fever, chills, and headache was recovered on 21Mar2021.  The clinical outcome of fatigue, vomiting, and nausea was recovering.   No follow-up attempts are possible. No further information is expected.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain, Vomiting
Clinical narrative: Vomiting; Nausea; Pain at injection site; Fever; Chills; Headache; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 25-year-old non pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6208; Dose: UNKNOWN) via an unspecified route of administration in the left arm on 19Mar2021 at 16:00, (at the age of 25 years old) as a single dose for COVID-19 immunisation. Medical history included asthma and irritable bowel syndrome. The patient was allergic to dairy products. Concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 19Mar2021, the patient experienced pain at injection site, fever, chills, headache, and fatigue. On 22Mar2021, the patient experienced vomiting, and nausea. No therapeutic measures were taken as result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of events pain at injection site, fever, chills, and headache was recovered on 21Mar2021.  The clinical outcome of fatigue, vomiting, and nausea was recovering.   No follow-up attempts are possible. No further information is expected.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Decreased appetite, Fatigue, Myalgia, Nausea
Clinical narrative: 24 hours post vaccine developed fever (101); Nausea; lack of appetite; muscle aches (entire body); Fatigue; This is a spontaneous report received from a contactable health care professional, the patient. A 60-year-old non-pregnant female patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: FR2613) via an unspecified route of administration in the right arm on 19Mar2021 at 16:00 (at the age of 60-years-old), as a single dose for COVID-19 immunisation. Medical history was not reported. The patient was allergic to sulpha. The concomitant medications included losartan (MANUFACTURER UNKNOWN), felodipine (MANUFACTURER UNKNOWN), omeprazole (MANUFACTURER UNKNOWN), CRESTOR and CARVIDEX; all for unknown indications from unknown dates. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Since the vaccination, the patient was tested for COVID-19, but the result was unknown. On 20Mar2021 at 16:00, the patient experienced fever of 101 (units unspecified), nausea, lack of appetite, muscle aches (entire body) and fatigue. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient was treated with TYLENOL for the reported events. The clinical outcome of the events fever, nausea, lack of appetite, muscle aches and fatigue were resolved on an unknown date in Mar2021. No follow-up attempts possible. No further information expected.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: 24 hours post vaccine developed fever (101); Nausea; lack of appetite; muscle aches (entire body); Fatigue; This is a spontaneous report received from a contactable health care professional, the patient. A 60-year-old non-pregnant female patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: FR2613) via an unspecified route of administration in the right arm on 19Mar2021 at 16:00 (at the age of 60-years-old), as a single dose for COVID-19 immunisation. Medical history was not reported. The patient was allergic to sulpha. The concomitant medications included losartan (MANUFACTURER UNKNOWN), felodipine (MANUFACTURER UNKNOWN), omeprazole (MANUFACTURER UNKNOWN), CRESTOR and CARVIDEX; all for unknown indications from unknown dates. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Since the vaccination, the patient was tested for COVID-19, but the result was unknown. On 20Mar2021 at 16:00, the patient experienced fever of 101 (units unspecified), nausea, lack of appetite, muscle aches (entire body) and fatigue. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient was treated with TYLENOL for the reported events. The clinical outcome of the events fever, nausea, lack of appetite, muscle aches and fatigue were resolved on an unknown date in Mar2021. No follow-up attempts possible. No further information expected.
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Lymph node pain, Lymphadenopathy, Pain
Clinical narrative: Achy body; Slightly weak; Developed a swollen and tender lymph node on base of neck by collar bone (left side); Developed a swollen and tender lymph node on base of neck by collar bone (left side); This is a spontaneous report from a contactable consumer, the patient. A 44-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 19Mar2021 at 10:30 (at the age of 44-year-old) as a single dose for COVID-19 immunisation. The patient medical history included hypothyroidism and hashimotos disease. The patient had no allergies to medications, food, or other products. Concomitant medications within two weeks of vaccination included levoxothyrine (MANUFACTURER UNKNOWN) for an unknown indication and from an unknown date. The patient previously received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 26Feb2021 at 10:30 (at the age of 44-year-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Since the vaccination, the patient had not been tested positive for COVID-19. On 20Mar2021 at 12:00, the patient developed a swollen and tender lymph node on base of neck by collar bone (left side) about 24-27 hours after vaccine. On 21Mar2021, the patient had slightly weak and achy body for a few hours but nothing more severe. No headache, fever, chills. Just sore swollen lymph node. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events The clinical outcome of the events swollen and tender lymph node on base of neck by collar bone (left side), achy body and slightly weak were not resolved at the time of this report.   Information about lot/ batch number cannot be obtained. No further information expected.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: Severe body aches like the flu; This is a spontaneous report from a contactable other healthcare professional, the patient. A 46-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration on 08Mar2021 (at the age of 46-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient did not receive any other medications within 2 weeks of vaccination.  Prior to the vaccination, it was unknown if the patient was diagnosed with COVID-19. Since the vaccination, the patient had not tested positive for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient experienced severe body aches like the flu on 09Mar2021. No therapeutic measures were taken as result of the event. The clinical outcome of the event severe body aches like the flu was resolved (which lasted for one and half days) on 11Mar2021.   Information about lot/batch number cannot be obtained. No further information is expected.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Bone pain, Fatigue, Headache, Myalgia, Nausea
Clinical narrative: Bone aches; Headache; Fatigue; Nausea; Muscle aches; This is a spontaneous report from a non-contactable consumer, the patient. A 36-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8730) via unspecified route of administration in right arm on 21Mar2021 at 1200 (at the age of 36-year-old) as a single dose for COVID-19 immunisation. Medical history included dysautonomia. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested positive for COVID-19. It was reported that the patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medication was not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: unknown), via an unspecified route of administration in right arm on 26Feb2021 at 1200 (at the age of 36-year-old), as a single dose for COVID-19 immunisation. On 21Mar2021 at 1500, the patient experienced headache, fatigue, nausea, muscle aches and bone aches. The events did not result in doctor or other healthcare professional office/clinic visit. The patient did not receive any treatment for the events. The clinical outcome of headache, fatigue, nausea, muscle aches and bone aches was recovering at the time of this report.   Information about lot/batch number cannot be obtained. No further information is expected.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Chills, Fatigue, Headache, Pain
Clinical narrative: This is a spontaneous report received from a contactable consumer, the patient. A 52-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6208) via an unspecified route of administration on the left arm on 20Mar2021 at 13:00 (at the age of 52-years-old) as a single dose, for COVID-19 immunisation. Medical history not reported. Concomitant medications included probiotic (MANUFACTURER UNKNOWN), ZYRTEC and multivitamin (MANUFACTURER UNKNOWN). The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6198) via an unspecified route of administration on the left arm on 27Feb2021 at 13:30 (at the age of 52-years-old) as a single dose, for COVID-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested positive for COVID-19. The patient experienced fever, chills, headache, body ache, stomach pain, fatigue, tingles in finger tips, sleepy (slept for hours), body sensitive to touch and puffy eyes on 21Mar2021 at 06:00. Treatment was not received for the adverse events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of events fever, chills, headache, body ache, stomach pain, fatigue, tingles in finger tips, sleepy (slept for hours), body sensitive to touch and puffy eyes were recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia, Periorbital swelling, Pyrexia, Somnolence
Clinical narrative: This is a spontaneous report received from a contactable consumer, the patient. A 52-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6208) via an unspecified route of administration on the left arm on 20Mar2021 at 13:00 (at the age of 52-years-old) as a single dose, for COVID-19 immunisation. Medical history not reported. Concomitant medications included probiotic (MANUFACTURER UNKNOWN), ZYRTEC and multivitamin (MANUFACTURER UNKNOWN). The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6198) via an unspecified route of administration on the left arm on 27Feb2021 at 13:30 (at the age of 52-years-old) as a single dose, for COVID-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested positive for COVID-19. The patient experienced fever, chills, headache, body ache, stomach pain, fatigue, tingles in finger tips, sleepy (slept for hours), body sensitive to touch and puffy eyes on 21Mar2021 at 06:00. Treatment was not received for the adverse events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of events fever, chills, headache, body ache, stomach pain, fatigue, tingles in finger tips, sleepy (slept for hours), body sensitive to touch and puffy eyes were recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: complained of a sore arm; This is a spontaneous report from a other healthcare professional. A 20-year-old non-pregnant female patient received an unspecified dose of BNT162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot number: unknown) via intramuscular route of administration in the left arm on 20Mar2021 at 14:00 (at the age of 20-years-old) as a single dose for COVID-19 immunisation. The patient's medical history was not provided. Concomitant medication taken in two weeks included medication for birth control (MANUFACTURER UNKNOWN) on an unknown date. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested positive for COVID-19. On 21Mar2021 at 11:00, patient complained of a sore arm. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the event sore arm. The clinical outcome of the event sore arm was recovering.  Information about lot/batch number cannot be obtained. No further information is expected
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Decreased appetite, Diarrhoea, Fatigue, Headache
Clinical narrative: Fever; Severe body aches; Headache; Diarrhea; Loss of appetite; Tired; Unwell; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old male patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via an unspecified route of administration in the left arm on 18Mar2021 at 11:00 (at the age of 54-year-old), as a single dose for COVID-19 immunisation. Medical history was not reported. The patient did not have any allergies to medications, food or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any medication within two weeks of vaccine. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 18Mar2021 at 11:00, the patient experienced initially tiredness and unwell feeling. fever up to 103, severe body aches, headache, diarrhoea and loss of appetite. Three days later severe symptoms started and still ongoing (unknown date) over 4 days later. The patient might seek medical attention if not the condition becomes better. The patient not received treatment for the adverse events. The clinical outcome of the events tiredness, unwell, fever, severe body aches, headache, diarrhoea and loss of appetite were not resolved at the time of this report.   No follow-up attempts are possible; information about lot number cannot be obtained.
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Malaise, Pain, Pyrexia
Clinical narrative: Fever; Severe body aches; Headache; Diarrhea; Loss of appetite; Tired; Unwell; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old male patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via an unspecified route of administration in the left arm on 18Mar2021 at 11:00 (at the age of 54-year-old), as a single dose for COVID-19 immunisation. Medical history was not reported. The patient did not have any allergies to medications, food or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any medication within two weeks of vaccine. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 18Mar2021 at 11:00, the patient experienced initially tiredness and unwell feeling. fever up to 103, severe body aches, headache, diarrhoea and loss of appetite. Three days later severe symptoms started and still ongoing (unknown date) over 4 days later. The patient might seek medical attention if not the condition becomes better. The patient not received treatment for the adverse events. The clinical outcome of the events tiredness, unwell, fever, severe body aches, headache, diarrhoea and loss of appetite were not resolved at the time of this report.   No follow-up attempts are possible; information about lot number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Dizziness, Nausea, SARS-CoV-2 test
Clinical narrative: Light headed; nauseous; Diarrhea; This is a spontaneous report from a non-contactable consumer, the patient. A 38-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via the unspecified route of administration in the left arm on 17Mar2021 as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no allergies to medications, food, or other products. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any other medications within 2 weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. It was unknown if the patient was pregnant at the time of vaccination. The events did not result in doctor or other healthcare professional office or clinic visits, emergency room or department, or urgent care. On 19Mar2021, the patient experienced lightheaded, nauseous and diarrhoea for 5 days after vaccination. Since the vaccination, the patient had been tested for COVID-19. On 20Mar2021, the patient underwent a nasal swab test and the result was negative. The patient did not receive treatment for the events. The clinical outcome for the event diarrhoea was recovered on 24Mar2021; while the events of lightheaded and nauseous were not recovered at the time of this report.   Information about lot/batch number cannot be obtained. No further information is expected.